Combination therapy with intranasal NGF and electroacupuncture enhanced cell proliferation and survival in rats after stroke
- PMID: 19061539
- DOI: 10.1179/174313209X382557
Combination therapy with intranasal NGF and electroacupuncture enhanced cell proliferation and survival in rats after stroke
Abstract
Objective: This work was designed to investigate the effects of the combination therapy with intranasal (IN) administration of nerve growth factor (NGF) and electroacupuncture (EA) on neural progenitors and neurological functional recovery in adult rats after focal ischemia.
Methods: Rats subjected to 2 hours of middle cerebral artery occlusion (MCAO) were randomly assigned to four groups: Group 1, IN administration of phosphate-buffered saline (PBS) for control; Group 2, IN administration of NGF alone; Group 3, EA with IN administration of PBS; Group 4, IN administration of NGF with EA. Treatments were initiated at 2 hours after MCAO and continued for three consecutive days. All animals received daily injections of 5-bromodeoxyuridine (BrdU) intraperitoneally for 7 days starting at 24 hours after reperfusion and were killed at 2 hours or 21 days after the last BrdU injection. Neurological function and infarct volume were evaluated. Immunohistochemistry for BrdU was performed to identify newborn cells in the ipsilateral subventricular zone and striatum.
Results: The combination treatment led to significant improvement in neurological function and reduction in infarct volume. Cell proliferation and survival of progenitors were enhanced in rats treated with the combination treatment.
Conclusion: These results suggest that IN administration of NGF and EA may have a synergistic effect in preventing ischemic injury and enhancing functional recovery after focal cerebral ischemia, which may be attributed to enhanced cell proliferation and survival.
Similar articles
-
Intranasal nerve growth factor enhances striatal neurogenesis in adult rats with focal cerebral ischemia.Drug Deliv. 2011 Jul;18(5):338-43. doi: 10.3109/10717544.2011.557785. Epub 2011 Feb 24. Drug Deliv. 2011. PMID: 21348576
-
Acidic fibroblast growth factor delivered intranasally induces neurogenesis and angiogenesis in rats after ischemic stroke.Neurol Res. 2011 Sep;33(7):675-80. doi: 10.1179/1743132810Y.0000000004. Neurol Res. 2011. PMID: 21756545
-
Intranasally delivered bFGF enhances neurogenesis in adult rats following cerebral ischemia.Neurosci Lett. 2008 Nov 28;446(1):30-5. doi: 10.1016/j.neulet.2008.09.030. Epub 2008 Sep 19. Neurosci Lett. 2008. PMID: 18822350
-
Treatment with edaravone attenuates ischemic brain injury and inhibits neurogenesis in the subventricular zone of adult rats after focal cerebral ischemia and reperfusion injury.Neuroscience. 2012 Jan 10;201:297-306. doi: 10.1016/j.neuroscience.2011.11.005. Epub 2011 Nov 15. Neuroscience. 2012. PMID: 22116052
-
Exploring the cellular and molecular basis of nerve growth factor in cerebral ischemia recovery.Neuroscience. 2025 Feb 6;566:190-197. doi: 10.1016/j.neuroscience.2024.12.049. Epub 2024 Dec 30. Neuroscience. 2025. PMID: 39742942 Review.
Cited by
-
The reporting quality of acupuncture for neurogenesis in experimental ischemic stroke study.Ann Transl Med. 2019 Mar;7(6):123. doi: 10.21037/atm.2019.02.16. Ann Transl Med. 2019. PMID: 31032278 Free PMC article.
-
Long-Term Intranasal Nerve Growth Factor Treatment Favors Neuron Formation in de novo Brain Tissue.Front Cell Neurosci. 2022 Jul 19;16:871532. doi: 10.3389/fncel.2022.871532. eCollection 2022. Front Cell Neurosci. 2022. PMID: 35928573 Free PMC article.
-
Targeting PI3K/Akt in Cerebral Ischemia Reperfusion Injury Alleviation: From Signaling Networks to Targeted Therapy.Mol Neurobiol. 2024 Oct;61(10):7930-7949. doi: 10.1007/s12035-024-04039-1. Epub 2024 Mar 5. Mol Neurobiol. 2024. PMID: 38441860 Review.
-
Mechanisms of Acupuncture Therapy for Cerebral Ischemia: an Evidence-Based Review of Clinical and Animal Studies on Cerebral Ischemia.J Neuroimmune Pharmacol. 2017 Dec;12(4):575-592. doi: 10.1007/s11481-017-9747-4. Epub 2017 May 19. J Neuroimmune Pharmacol. 2017. PMID: 28527041 Review.
-
The CB₁ receptor-mediated endocannabinoid signaling and NGF: the novel targets of curcumin.Neurochem Res. 2012 May;37(5):1112-20. doi: 10.1007/s11064-012-0716-2. Epub 2012 Feb 7. Neurochem Res. 2012. PMID: 22311129
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources